Digipath AI Test

Digipath AI: India’s Largest Cancer Prevention Platform

Mission

Empowering early detection and prevention of cervical and oral cancer.

Technology

Combining DNA Ploidy Testing (quantitative measurement of cell aneuploidy, the fundamental biomarker of cancer) with VELscope Vx Fluorescence Visualization for advanced cancer prevention and treatment solutions.

Vision

Making digital pathology and AI-powered diagnostics accessible, affordable, and easy to integrate into any clinical or research setting.

Inventors and Pioneers of
DNA Ploidy Technology

Dr Branko Palcic                           

Co Founder
Founder and former Head of Cancer Imaging, BC Cancer Agency. Professor Emeritus, BC Cancer Research.

Co-developer of the Cellular DNA Ploidy Analysis System for detecting malignancies via DNA content.
Pioneered AI-driven automation of DNA ploidy analysis, enhancing early cancer detection.
Advanced affordable, efficient cancer screening, particularly for low-resource settings.

Dr. Alfred Böcking
Scientific Advisor
Former Head of Cytopathology, University Hospital of Düsseldorf.
Globally recognized for expertise in quantitative DNA assessment.

Co-developer of the Cellular DNA Ploidy Analysis System. Advanced early detection and treatment of cervical cancer and other malignancies.

Influenced development of automated, AI-driven pathology tools for improved screening.

Technology developers

Global Reach & Innovation

Global Presence:

Robust market presence in the United States, Spain, Germany, Hong Kong, and beyond.

Solutions implemented in clinical and research settings at renowned organizations such as Cleveland Clinic and Memorial Sloan Kettering Cancer Center.

Innovation Team:

Over 300 dedicated R&D engineers and technicians driving continuous innovation in digital pathology and AI.

Quality Commitment:

ISO9001, ISO14001, and ISO13485 certified.

Vertically integrated manufacturing for superior performance and reliability

Clients

Why Choose Digipath AI?

Advanced Technology:

AI-powered DNA Ploidy and VELscope Vx for early, accurate cancer detection.

Global Recognition:

Trusted by leading international cancer centers.

Quality & Innovation:

ISO-certified, vertically integrated manufacturing, and a large R&D team.

The Team